During the past decade, Saint Louis University Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 28 clinical trials were completed, i.e. on average, 466.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 8 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Louis University Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 29 trials, followed by "NSABP Foundation Inc" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "Gynecologic Oncology Group" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Louis University Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Saint Louis University Cancer Center" are "Breast Cancer" (12 trials), "Lung Cancer" (10 trials), "Leukemia" (8 trials), "Colorectal Cancer" (7 trials) and "Head and Neck Cancer" (6 trials). Many other conditions were trialed in "Saint Louis University Cancer Center" in a lesser frequency.

Most popular intervention types in "Saint Louis University Cancer Center" are "Drug" (59 trials), "Radiation" (16 trials), "Other" (13 trials), "Procedure" (11 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (10 trials), "radiation therapy" (10 trials), "cyclophosphamide" (8 trials), "docetaxel" (6 trials) and "paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Saint Louis University Cancer Center" are 57 trials for "All" genders, 17 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Louis University Cancer Center". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Saint Louis University Cancer Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Louis University Cancer Center, 1 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Saint Louis University Cancer Center has several departments that took part in Clinical trials: "St. Louis ConnectCare, Infectious Diseases Clinic" - 38 trials, "Movement Disorders Center" - 2 trials